These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8397674)

  • 21. Non-nucleoside inhibitors of herpesviruses.
    Wathen MW
    Rev Med Virol; 2002; 12(3):167-78. PubMed ID: 11987142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Anti-herpes chemotherapy].
    Ingrand D
    Rev Prat; 1999 Dec; 49(20):2237-41. PubMed ID: 10731809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A short commentary on the review by Weller and Kuchta: the DNA helicase-primase complex as a target for herpes virus infection.
    Field HJ
    Expert Opin Ther Targets; 2013 Oct; 17(10):1113-4. PubMed ID: 24044544
    [No Abstract]   [Full Text] [Related]  

  • 24. Antiviral therapy: current options and challenges.
    Reusser P
    Schweiz Med Wochenschr; 2000 Jan; 130(4):101-12. PubMed ID: 10780051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Valacyclovir for the management of herpes viral infections.
    Chakrabarty A; Anderson NJ; Beutner R; Tyring SK
    Skin Therapy Lett; 2005 Feb; 10(1):1-4. PubMed ID: 15776202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Drugs active against herpesviruses].
    Fillet AM
    Rev Prat; 1997 Mar; 47(6):623-30. PubMed ID: 9183936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antivirals against DNA viruses (hepatitis B and the herpes viruses).
    Hewlett G; Hallenberger S; Rübsamen-Waigmann H
    Curr Opin Pharmacol; 2004 Oct; 4(5):453-64. PubMed ID: 15351349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiviral activity of Arthrospira-derived spirulan-like substances.
    Rechter S; König T; Auerochs S; Thulke S; Walter H; Dörnenburg H; Walter C; Marschall M
    Antiviral Res; 2006 Dec; 72(3):197-206. PubMed ID: 16884788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiviral drugs in the immunocompetent host: part I. Treatment of hepatitis, cytomegalovirus, and herpes infections.
    Colgan R; Michocki R; Greisman L; Moore TA
    Am Fam Physician; 2003 Feb; 67(4):757-62, 675. PubMed ID: 12613729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-herpesvirus agents: a patent and literature review (2003 to present).
    Skoreński M; Sieńczyk M
    Expert Opin Ther Pat; 2014 Aug; 24(8):925-41. PubMed ID: 25010889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pyrazolopyrimidines and pyrazolotriazines with potent activity against herpesviruses.
    Gudmundsson KS; Johns BA; Weatherhead J
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5689-92. PubMed ID: 19700316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pyrazolo[1,5-a]pyridine antiherpetics: effects of the C3 substituent on antiviral activity.
    Johns BA; Gudmundsson KS; Allen SH
    Bioorg Med Chem Lett; 2007 May; 17(10):2858-62. PubMed ID: 17350256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advances in antiviral therapy.
    Wu JJ; Pang KR; Huang DB; Tyring SK
    Dermatol Clin; 2005 Apr; 23(2):313-22. PubMed ID: 15837157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer biology. III. Herpes virus epidemiology, molecular events, oncogenicity and therapy.
    Adv Pathobiol; 1976; (5):1-176. PubMed ID: 220850
    [No Abstract]   [Full Text] [Related]  

  • 35. Small RNAs growing tall: miRNAs as drug targets in herpesvirus infections.
    L'Hernault A; Dölken L
    Curr Opin Virol; 2015 Dec; 15():41-7. PubMed ID: 26256575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Latency and acquired resistance--problems in chemotherapy of herpes infections.
    Darby G; Field HJ
    Pharmacol Ther; 1983; 23(2):217-51. PubMed ID: 6322214
    [No Abstract]   [Full Text] [Related]  

  • 37. Antiviral Research--16th International Conference: 27 April-1 May 2003, Savannah, GA, USA.
    Vere Hodge A
    IDrugs; 2003 Jun; 6(6):512-4. PubMed ID: 12861972
    [No Abstract]   [Full Text] [Related]  

  • 38. Herpes virus infections, HIV, and disease progression. Guarded optimism.
    Bartlett J
    AIDS Clin Care; 1995 Feb; 7(2):15. PubMed ID: 12212538
    [No Abstract]   [Full Text] [Related]  

  • 39. European survey of herpesvirus resistance to antiviral drugs in bone marrow transplant recipients. Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
    Reusser P; Cordonnier C; Einsele H; Engelhard D; Link D; Locasciulli A; Ljungman P
    Bone Marrow Transplant; 1996 May; 17(5):813-7. PubMed ID: 8733703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Herpes virus infections, HIV, and disease progression.
    Stein DS
    AIDS Clin Care; 1995 Feb; 7(2):11-4, 18. PubMed ID: 12212537
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.